Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 2
1960 1
1964 1
1971 2
1973 2
1975 1
1976 1
1977 2
1978 2
1980 3
1981 1
1982 4
1983 2
1984 2
1985 8
1986 7
1987 10
1988 10
1989 13
1990 11
1991 9
1992 7
1993 16
1994 21
1995 16
1996 13
1997 18
1998 15
1999 22
2000 20
2001 18
2002 26
2003 30
2004 39
2005 76
2006 86
2007 100
2008 119
2009 123
2010 142
2011 191
2012 225
2013 249
2014 295
2015 355
2016 343
2017 365
2018 414
2019 506
2020 604
2021 695
2022 817
2023 841
2024 967
2025 1120
2026 76

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8,072 results

Results by year

Filters applied: . Clear all
Page 1
Modification of belantamab mafodotin dosing to balance efficacy and tolerability in the DREAMM-7 and DREAMM-8 trials.
Mateos MV, Trudel S, Quach H, Robak P, Beksac M, Pour L, Hus M, Kim K, Zherebtsova V, Delimpasi S, Jelínek T, Ward C, Ho PJ, Vorobyev V, Pitombeira de Lacerda M, Aparecida-Martinez G, Spicka I, Radocha J, Cavo M, Cerchione C, Fu C, Suzuki K, Rogers R, Phillips-Jones A, Wang Z, Baig H, Wilkes J, Zhou XL, Lewis E, Eccersley L, Sule N, Paka P, Opalinska JB, Mukhopadhyay P, Hungria V, Dimopoulos MA. Mateos MV, et al. Among authors: fu c. Blood Adv. 2025 Nov 25;9(22):5708-5719. doi: 10.1182/bloodadvances.2025016949. Blood Adv. 2025. PMID: 40763276 Free PMC article. Clinical Trial.
Consensus Guidelines and Recommendations for the anti-CD38-based Therapy in Clinical Practice for Relapsed/Refractory Multiple Myeloma: From the Pan-Pacific Multiple Myeloma Working Group.
Chen W, Cai Z, Chim CS, Chng WJ, Du J, Fu C, Gao W, Hanamura I, Hou J, Huang JS, Ishida T, Li C, Liu A, Ptushkin V, Takezako N, Wong RSM, Yoon DH. Chen W, et al. Among authors: fu c. Clin Hematol Int. 2025 Aug 8;7(3):36-59. doi: 10.46989/001c.141401. eCollection 2025. Clin Hematol Int. 2025. PMID: 40786241 Free PMC article. Review.
In vivo CRISPR screening in head and neck cancer reveals Uchl5 as an immunotherapy target.
Fu C, Saddawi-Konefka R, Chinai JM, Kim SY, Kammula AV, Perera JJ, Jiang A, Tiwari P, Kistler EN, Tang S, Luna SM, Colvin KJ, Dubrot J, Anderson S, Fetterman RA, Chuong CL, Lane-Reticker SK, Cheruiyot CK, Muscato AJ, Alipour Z, Adkins DR, Griffin GK, Bernstein BE, Egloff AM, Yates KB, Chernock RD, Gutkind JS, Uppaluri R, Manguso RT. Fu C, et al. Nat Commun. 2025 Sep 29;16(1):8572. doi: 10.1038/s41467-025-63592-y. Nat Commun. 2025. PMID: 41022734 Free PMC article.
8,072 results